Home » AlzeCure Presents at Aktiespararna’s Smabolagsdagarna on June 13

AlzeCure Presents at Aktiespararna’s Smabolagsdagarna on June 13

by admin
AlzeCure Presents at Aktiespararna’s Smabolagsdagarna on June 13

STOCKHOLM, SE / ACCESSWIRE / June 8, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the …

STOCKHOLM, SE / ACCESSWIRE / June 8, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad
portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company will participate
at Småbolagsdagarna in Stockholm, Sweden, on June 13 at 14:20 CET. CEO Martin Jönsson will present the latest development of the company, including the recently presented positive phase II results
with ACD440 in neuropathic pain.

Småbolagsdagarna will be held at Birger Jarl Konferens, Birger Jarlsgatan 61 A in Stockholm, Sweden, on June 12-14, and is organized by Aktiespararna, the world‘s largest member organization for
private individuals who save in shares and funds.

See also  the trailer with Sylvester Stallone and Jason Statham

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy